Edition:
India

Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,614.50GBp
20 Jul 2018
Change (% chg)

66.50 (+4.30%)
Prev Close
1,548.00
Open
1,548.00
Day's High
1,650.00
Day's Low
1,548.00
Volume
1,066,665
Avg. Vol
600,511
52-wk High
1,650.00
52-wk Low
814.20

Select another date:

Wed, Jul 18 2018

Photo

Hikma raising injectable opioids output to help ease shortage at U.S. hospitals

LONDON London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.

Hikma raising injectable opioids output to help ease shortage at U.S. hospitals

LONDON, July 18 London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.

GSK wins new reprieve as Hikma's generic Advair delayed again

GlaxoSmithKline has won a further reprieve for its blockbuster Advair lung drug after U.S. regulators insisted Hikma Pharmaceuticals conduct a further clinical study evaluating its generic version of the drug.

BRIEF-Hikma Gets U.S. FDA Response On ANDA For Generic Version Of GSK's Advair Diskus

* HAS RECEIVED A RESPONSE FROM U.S. FDA IN RELATION TO ITS ANDA FOR ITS GENERIC VERSION OF GLAXOSMITHKLINE'S ADVAIR DISKUS

Hikma plans new clinical study over generic Advair

March 12 Hikma Pharmaceuticals Plc said on Monday it plans a new clinical study on its generic version of GlaxoSmithKline's popular lung drug Advair, as it looks to resolve an ongoing dispute with the Food and Drug Administration over plans to launch the drug in the U.S.

UPDATE 1-Drugmaker Hikma names former Teva exec Olafsson as CEO; shares up

Feb 20 Hikma Pharmaceuticals Plc named former Teva Pharmaceutical executive Sigurdur Olafsson as its CEO, as the Jordan-based drugmaker looks to improve its struggling generics business.

BRIEF-Hikma Pharmaceutical Names Sigurdur Olafsson As CEO

* SAYS OLAFSSON WILL ALSO JOIN HIKMA'S BOARD OF DIRECTORS AS AN EXECUTIVE DIRECTOR

Drugmaker Hikma appoints Sigurdur Olafsson as CEO

Feb 20 Drugmaker Hikma Pharmaceuticals Plc said on Tuesday it appointed Sigurdur Olafsson as its chief executive, effective immediately.

Select another date: